273 related articles for article (PubMed ID: 8878583)
21. Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.
Kosowska K; Hoellman DB; Lin G; Clark C; Credito K; McGhee P; Dewasse B; Bozdogan B; Shapiro S; Appelbaum PC
Antimicrob Agents Chemother; 2005 May; 49(5):1932-42. PubMed ID: 15855516
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.
Jones RN; Ballow CH; Biedenbach DJ; Deinhart JA; Schentag JJ
Diagn Microbiol Infect Dis; 1998 Jul; 31(3):437-51. PubMed ID: 9635235
[TBL] [Abstract][Full Text] [Related]
23. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Jan; 41(1):148-55. PubMed ID: 8980771
[TBL] [Abstract][Full Text] [Related]
24. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1992 Apr; 36(4):856-9. PubMed ID: 1323956
[TBL] [Abstract][Full Text] [Related]
25. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae.
Martin SJ; Garvin CG; McBurney CR; Sahloff EG
J Antimicrob Chemother; 2001 May; 47(5):581-7. PubMed ID: 11328768
[TBL] [Abstract][Full Text] [Related]
26. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R
Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591
[TBL] [Abstract][Full Text] [Related]
27. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
Spangler SK; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1997 Feb; 39(2):141-8. PubMed ID: 9069533
[TBL] [Abstract][Full Text] [Related]
28. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
[TBL] [Abstract][Full Text] [Related]
29. Antipneumococcal activity of MEN 10700, a new penem, compared with other compounds, by MIC and time-kill kinetics.
Pankuch GA; Hoellman DB; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1999 Sep; 44(3):381-4. PubMed ID: 10511406
[TBL] [Abstract][Full Text] [Related]
30. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
[TBL] [Abstract][Full Text] [Related]
31. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 1998 Apr; 42(4):945-6. PubMed ID: 9559816
[TBL] [Abstract][Full Text] [Related]
32. Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin.
Klugman KP; Capper T
J Antimicrob Chemother; 1997 Dec; 40(6):797-802. PubMed ID: 9462430
[TBL] [Abstract][Full Text] [Related]
33. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
[TBL] [Abstract][Full Text] [Related]
34. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Feb; 40(2):481-4. PubMed ID: 8834904
[TBL] [Abstract][Full Text] [Related]
35. [Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
Sener B; Köseoğlu O; Fişenk I; Hasçelik G; Günalp A
Mikrobiyol Bul; 2002 Apr; 36(2):125-31. PubMed ID: 12652863
[TBL] [Abstract][Full Text] [Related]
36. Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
Biedenbach D; Wanger A; Jones RN
J Antimicrob Chemother; 1996 Sep; 38(3):553-5. PubMed ID: 8889731
[No Abstract] [Full Text] [Related]
37. Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae in southwestern Japan and correlation of penicillin-binding protein 2b and 2x mutations in susceptibilities of penicillin G and cefotaxime.
Nagai K; Matsuo Y; Tsumura N; Sakata Y; Kato H
Diagn Microbiol Infect Dis; 2000 Jun; 37(2):107-13. PubMed ID: 10863105
[TBL] [Abstract][Full Text] [Related]
38. Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
Betriu C; Redondo M; Palau ML; Sánchez A; Gómez M; Culebras E; Boloix A; Picazo JJ
Antimicrob Agents Chemother; 2000 Jul; 44(7):1838-41. PubMed ID: 10858339
[TBL] [Abstract][Full Text] [Related]
39. In vitro antimicrobial activity and MIC quality control guidelines of RPR 106972 (RPR 112808/RPR106950): a novel orally administered streptogramin combination. The Quality Control Study Group.
Putnam SD; Jones RN; Johnson DM
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):139-47. PubMed ID: 9294704
[TBL] [Abstract][Full Text] [Related]
40. Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci.
Fasola E; Spangler SK; Ednie LM; Jacobs MR; Bajaksouzian S; Appelbaum PC
Antimicrob Agents Chemother; 1996 Nov; 40(11):2661-3. PubMed ID: 8913486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
